# FDA Inspection 1016853 - Michael Bukhalo, M.D. - May 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/michael-bukhalo-md/eee8c351-1bc8-4285-a572-ef0e32901c70
Source feed: FDA_Inspections

> FDA Inspection 1016853 for Michael Bukhalo, M.D. on May 30, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016853
- Company Name: Michael Bukhalo, M.D.
- Inspection Date: 2017-05-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1125735 - 2020-07-16](https://www.keypedia.com/records/fda_inspections/michael-bukhalo-md/51ce3dc2-7e9d-4b68-8342-2234cc29bb32)
- [FDA Inspection 931955 - 2015-07-21](https://www.keypedia.com/records/fda_inspections/michael-bukhalo-md/6fb74789-c41f-406a-806d-0d5e6ec86fe4)

Company: https://www.keypedia.com/companies/michael-bukhalo-md/d91befc0-c959-484a-aeec-6be22b54775b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c